Actual Medicinal Product (AMP) - ReQuip XL 4mg tablets (GlaxoSmithKline UK Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name ReQuip XL 4mg tablets | Start Date 02-06-2008 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 04090100 | Start Date 19-11-2008 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 13628411000001102 | 02-06-2008 |
Parent Products
-
VTMRopinirole
-
VMPRopinirole 4mg modified-release tablets
-
AMP(Current) ReQuip XL 4mg tablets (GlaxoSm... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet | 2509 |